NKTR Howard W Robin sells $84K worth of shares
Dec 20, 2024, 5:32 AM
-4.09%
What does NKTR do
Nektar Therapeutics, a San Francisco-based biopharmaceutical company with 137 employees, focuses on developing immunotherapy medicines for oncology and immunology, including NKTR-255 and Rezpegaldesleukin. Its pipeline targets immune response pathways to address cancer and autoimmune conditions.
Howard W Robin sold 85,035 shares of NKTR on 18 December at $0.99 per share, worth a total of $84K. They now own 1,110,675 NKTR shares, or a 7% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.